DONALD HOLE: Open Payments
NPI 1174671812 · SANTA MARIA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,094 in 130 payments from 18 companies in 2025. Trend: 2023 $3,670 · 2024 $2,453 · 2025 $2,094
Food & beverage: $2,094
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $357 |
| PFIZER INC. | 13 | $248 |
| Lilly USA, LLC | 11 | $241 |
| Novo Nordisk Inc | 11 | $202 |
| Amgen Inc. | 23 | $199 |
| GlaxoSmithKline, LLC. | 26 | $173 |
| AstraZeneca Pharmaceuticals LP | 5 | $151 |
| Novartis Pharmaceuticals Corporation | 5 | $146 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $82 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $78 |
Products named: MOUNJARO, UBRELVY, JARDIANCE, LEQVIO, OTEZLA, NURTEC ODT, TRELEGY ELLIPTA, Ozempic.
Industry payments across CA — which companies pay providers there.
